XML 171 R98.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Financial Information of Registrant - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities:      
Net cash provided by operating activities $ 644 $ 1,662 $ 773
Investing activities:      
Purchases of investments (1,132) (1,433) (1,913)
Proceeds from sales and maturities of investments 1,111 772 1,398
Purchases of property, equipment and capitalized software (100) (84) (91)
Other, net 1 4 (50)
Net cash used in investing activities (464) (744) (790)
Financing activities:      
Common stock purchases (1,000) 0 (400)
Proceeds from senior notes offerings, net of issuance costs 740 0 0
Proceeds from borrowings under credit facility 300 0 0
Repayment of credit facility (300) 0 0
Common stock withheld to settle employee tax obligations (57) (60) (54)
Contingent consideration liabilities settled 0 0 (20)
Other, net (30) 2 33
Net cash used in financing activities (347) (58) (441)
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents (167) 860 (458)
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period 4,908 4,048 4,506
Cash and cash equivalents, and restricted cash and cash equivalents at end of period 4,741 4,908 4,048
Parent Company      
Operating activities:      
Net cash provided by operating activities 63 81 119
Investing activities:      
Capital contributions to subsidiaries (490) (221) (159)
Dividends received from subsidiaries 997 705 668
Purchases of investments 0 (2) (29)
Proceeds from sales and maturities of investments 17 1 49
Purchases of property, equipment and capitalized software (97) (79) (86)
Net cash paid in business combinations (489) (74) 0
Change in amounts due to/from affiliates 60 5 (69)
Other, net 6 7 3
Net cash used in investing activities 4 342 377
Financing activities:      
Common stock purchases (1,000) 0 (400)
Proceeds from senior notes offerings, net of issuance costs 740 0 0
Proceeds from borrowings under credit facility 300 0 0
Repayment of credit facility (300) 0 0
Common stock withheld to settle employee tax obligations (57) (60) (54)
Contingent consideration liabilities settled 0 0 (20)
Other, net (30) 2 33
Net cash used in financing activities (347) (58) (441)
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents (280) 365 55
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period 694 329 274
Cash and cash equivalents, and restricted cash and cash equivalents at end of period $ 414 $ 694 $ 329